USPTO serial 77073950
SINUPRO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CORWIN, CHARLOTTE K
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SINUPRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | All purpose disinfecting and deodorizing preparations; Allergy medications; Allergy relief medication; Analgesic preparations; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-inflammatory and antipyretic preparations; Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Antibiotic preparations; Antifungal creams for medical use; Biological and chemical preparations and reagents for medical or veterinary use; Biological preparations for medical purposes; Cardiovascular treatment preparations; Cleansing solutions for medical use; Cold sore treatment preparations; Cotton swabs for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for medical or veterinary purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Fungal medications; Fungicides for medical use; Headache treatment preparations; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Hydrogen peroxide for medical use; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with antimicrobial and antiinflammation agents; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Medicated mouth care and treatment preparations; Medicated mouthwash; Medicinal herbal extracts for medical purposes; Medicinal preparations for the mouth and as sprays; Migraine treatment preparations; Mixed antibiotic preparations; Nasal spray preparations; Oxygen for medical use; Pain relief medication; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; Plant extracts for medical, veterinary and pharmaceutical purposes; Preparations for detecting genetic predispositions for medical purposes; Preparations for the treatment of asthma; Preparations for treating colds; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Reagents and media for medical and veterinary diagnostic purposes; Sanitary preparations for medical use; Sinus pillows containing aromatic substances for relief from headaches, insomnia and sinus discomfort; Smoking cessation preparations; Stimulatory medications for use in weight reduction programs | ABANDONED | Dec 27, 2006 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2010 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| Oct 6, 2010 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Oct 6, 2010 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jul 8, 2010 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Jan 5, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2008 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Aug 28, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jul 29, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 25, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 24, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2008 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 22, 2008 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 21, 2008 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 21, 2008 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 21, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 5, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 5, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 24, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jan 21, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2008 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jan 21, 2008 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Nov 29, 2007 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 29, 2007 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 28, 2007 | RFTP | REMOVED FROM TEAS PLUS | — |
| Apr 27, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 27, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 4, 2007 | NWAP | NEW APPLICATION ENTERED | — |